References
-
1
Detterbeck F C, Parsons A M.
Thymic tumors.
Ann Thor Surg.
2004;
77
1860-1869
-
2
Park B J, Bacchetta M, Bains M S. et al .
Surgical management of thoracic malignancies invading the heart or great vessels.
Ann Thor Surg.
2004;
78
1024-1030
-
3
Shimizu N, Date H, Moriyama S, Ando A, Teramoto S.
Reconstruction of the superior vena cava in patients with mediastinal malignancies.
Eur J Cardiothor Surg.
1991;
5
575-578
-
4
Chiu C J, Terzis J, MacRae M L.
Replacement of superior vena cava with the spiral composite vein graft: a versatile technique.
Ann Thor Surg.
1974;
17
555-560
-
5
Alimi Y S, Gloviczki P, Vrtiska T J. et al .
Reconstruction of the superior vena cava: benefits of postoperative surveillance and secondary endovascular interventions.
J Vasc Surg.
1998;
27
287-301
-
6
Dartevelle P G, Chapelier A R, Pastorino U. et al .
Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors.
J Thorac Cardiovasc Surg.
1991;
102
259-265
-
7
Kalra M, Gloviczki P, Andrews J C. et al .
Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease.
J Vasc Surg.
2003;
38
215-223
-
8
Courtheoux P, Alkofer B, Refai M A, Gervais R, Le Rochais J P, Icard P.
Stent placement in superior vena cava syndrome.
Ann Thor Surg.
2003;
75
158-161
MD, PhD Nicholas Charokopos
Cardiothoracic Surgeon
22, Grigoriou E' St., Panorama,
Thessaloniki 55236
Greece
Fax: + 30 23 10 99 48 71
Email: charokoposnick@hotmail.com
